Granite Point Capital Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Granite Point Capital Management’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-10,000	Closed	-$432K	–	120
2015 Q3	$432K	Sell	10,000 -117,464	-92%	-$4.96M	0.3%	66
2015 Q2	$5.39M	Sell	127,464 -52,536	-29%	-$2.22M	1.57%	7
2015 Q1	$6.98M	Buy	180,000 +100,000	+125%	+$3.85M	2.56%	5
2014 Q4	$2.69M	Buy	80,000 +10,000	+14%	+$353K	1.26%	13
2014 Q3	$2.45M	Hold	70,000	–	–	1.22%	14
2014 Q2	$2.3M	Sell	70,000 -32,000	-31%	-$1.1M	1.58%	13
2014 Q1	$3.76M	Buy	102,000 +51,996	+104%	+$1.91M	2.69%	6
2013 Q4	$1.92M	Buy	+50,004	New	+$1.58M	0.32%	30

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Granite Point Capital Management's WX Position: Q4 2015 in Review

Granite Point Capital Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 10,000 shares — an estimated $432K sold.

Granite Point Capital Management first reported a position in WX in Q4 2013 and held it in 8 quarters. The position peaked at $6.98M in Q1 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Granite Point Capital Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Granite Point Capital Management sold 10,000 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $432K.
Granite Point Capital Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q4 2013 and held it in 8 quarters.
Granite Point Capital Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $6.98M in Q1 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Granite Point Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.